Lifesci Capital Expects Reduced Earnings for Immunovant
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Lifesci Capital decreased their FY2025 earnings per share (EPS) estimates for shares of Immunovant in a report released on Sunday, February 23rd. Lifesci Capital analyst S. Slutsky now anticipates that the company will post earnings per share of ($2.64) for the year, down from their previous forecast of […]
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Lifesci Capital decreased their FY2025 earnings per share (EPS) estimates for shares of Immunovant in a report released on Sunday, February 23rd. Lifesci Capital analyst S. Slutsky now anticipates that the company will post earnings per share of ($2.64) for the year, down from their previous forecast of […]
